Cargando…

Evaluation of Olfactory Function With Objective Tests in COVID-19-Positive Patients: A Cross-Sectional Study

OBJECTIVE: Olfactory dysfunction is relatively high in coronavirus disease 2019 (COVID-19) patients. The aim of this study is to investigate the incidence of olfactory disorder objectively in patients with laboratory-confirmed COVID-19 infection. MATERIAL AND METHOD: The study included 31 healthy co...

Descripción completa

Detalles Bibliográficos
Autores principales: Gözen, E. Deniz, Aliyeva, Chinara, Tevetoğlu, Fırat, Karaali, Rıdvan, Balkan, İlker İnanç, Yener, H. Murat, Özdoğan, H. Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689254/
https://www.ncbi.nlm.nih.gov/pubmed/33236918
http://dx.doi.org/10.1177/0145561320975510
_version_ 1783613827401646080
author Gözen, E. Deniz
Aliyeva, Chinara
Tevetoğlu, Fırat
Karaali, Rıdvan
Balkan, İlker İnanç
Yener, H. Murat
Özdoğan, H. Ahmet
author_facet Gözen, E. Deniz
Aliyeva, Chinara
Tevetoğlu, Fırat
Karaali, Rıdvan
Balkan, İlker İnanç
Yener, H. Murat
Özdoğan, H. Ahmet
author_sort Gözen, E. Deniz
collection PubMed
description OBJECTIVE: Olfactory dysfunction is relatively high in coronavirus disease 2019 (COVID-19) patients. The aim of this study is to investigate the incidence of olfactory disorder objectively in patients with laboratory-confirmed COVID-19 infection. MATERIAL AND METHOD: The study included 31 healthy controls and 59 COVID-19 patients who were diagnosed and treated in the COVID departments in a tertiary hospital. The patients with corona virus infection were screened by a questionnaire and were classified into 2 groups as either group 2 (patients without self-reported smell loss) or group 3 (patients with self-reported smell loss). Age and gender matched healthy controls who do not have chronic nasal condition or nasal surgery history comprised the control group (group 1). All of the patients and subjects in the control group were tested by the Sniffin’ Sticks test. All of the answers and scores were recorded, and the comparisons were made. RESULTS: The rate of self-reported smell and taste loss in all COVID-19 patients in this study was 52.5% and 42%, respectively. There was a significant difference in threshold, discrimination, identification, and Threshold, Discrimination, Identification (TDI) scores between groups 1 and 2. When the comparisons between group 1 and 3 were made, again threshold, discrimination, identification, and TDI scores were significantly different. The comparison between groups 2 and 3 demonstrated a significant difference in discrimination, identification, and TDI scores, but threshold score was not different statistically. With questionnaire, the rate of olfactory dysfunction in COVID-19 patients was 52.5%, but with objective test, the rate was calculated as 83%. CONCLUSION: Olfactory and gustatory dysfunctions are common in COVID-19 patients. According to findings with the objective test method in this study, smell disorder in COVID-19 patients was much higher than those detected by questionnaires.
format Online
Article
Text
id pubmed-7689254
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-76892542020-12-03 Evaluation of Olfactory Function With Objective Tests in COVID-19-Positive Patients: A Cross-Sectional Study Gözen, E. Deniz Aliyeva, Chinara Tevetoğlu, Fırat Karaali, Rıdvan Balkan, İlker İnanç Yener, H. Murat Özdoğan, H. Ahmet Ear Nose Throat J Clinical Study OBJECTIVE: Olfactory dysfunction is relatively high in coronavirus disease 2019 (COVID-19) patients. The aim of this study is to investigate the incidence of olfactory disorder objectively in patients with laboratory-confirmed COVID-19 infection. MATERIAL AND METHOD: The study included 31 healthy controls and 59 COVID-19 patients who were diagnosed and treated in the COVID departments in a tertiary hospital. The patients with corona virus infection were screened by a questionnaire and were classified into 2 groups as either group 2 (patients without self-reported smell loss) or group 3 (patients with self-reported smell loss). Age and gender matched healthy controls who do not have chronic nasal condition or nasal surgery history comprised the control group (group 1). All of the patients and subjects in the control group were tested by the Sniffin’ Sticks test. All of the answers and scores were recorded, and the comparisons were made. RESULTS: The rate of self-reported smell and taste loss in all COVID-19 patients in this study was 52.5% and 42%, respectively. There was a significant difference in threshold, discrimination, identification, and Threshold, Discrimination, Identification (TDI) scores between groups 1 and 2. When the comparisons between group 1 and 3 were made, again threshold, discrimination, identification, and TDI scores were significantly different. The comparison between groups 2 and 3 demonstrated a significant difference in discrimination, identification, and TDI scores, but threshold score was not different statistically. With questionnaire, the rate of olfactory dysfunction in COVID-19 patients was 52.5%, but with objective test, the rate was calculated as 83%. CONCLUSION: Olfactory and gustatory dysfunctions are common in COVID-19 patients. According to findings with the objective test method in this study, smell disorder in COVID-19 patients was much higher than those detected by questionnaires. SAGE Publications 2021-04 /pmc/articles/PMC7689254/ /pubmed/33236918 http://dx.doi.org/10.1177/0145561320975510 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Clinical Study
Gözen, E. Deniz
Aliyeva, Chinara
Tevetoğlu, Fırat
Karaali, Rıdvan
Balkan, İlker İnanç
Yener, H. Murat
Özdoğan, H. Ahmet
Evaluation of Olfactory Function With Objective Tests in COVID-19-Positive Patients: A Cross-Sectional Study
title Evaluation of Olfactory Function With Objective Tests in COVID-19-Positive Patients: A Cross-Sectional Study
title_full Evaluation of Olfactory Function With Objective Tests in COVID-19-Positive Patients: A Cross-Sectional Study
title_fullStr Evaluation of Olfactory Function With Objective Tests in COVID-19-Positive Patients: A Cross-Sectional Study
title_full_unstemmed Evaluation of Olfactory Function With Objective Tests in COVID-19-Positive Patients: A Cross-Sectional Study
title_short Evaluation of Olfactory Function With Objective Tests in COVID-19-Positive Patients: A Cross-Sectional Study
title_sort evaluation of olfactory function with objective tests in covid-19-positive patients: a cross-sectional study
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689254/
https://www.ncbi.nlm.nih.gov/pubmed/33236918
http://dx.doi.org/10.1177/0145561320975510
work_keys_str_mv AT gozenedeniz evaluationofolfactoryfunctionwithobjectivetestsincovid19positivepatientsacrosssectionalstudy
AT aliyevachinara evaluationofolfactoryfunctionwithobjectivetestsincovid19positivepatientsacrosssectionalstudy
AT tevetoglufırat evaluationofolfactoryfunctionwithobjectivetestsincovid19positivepatientsacrosssectionalstudy
AT karaalirıdvan evaluationofolfactoryfunctionwithobjectivetestsincovid19positivepatientsacrosssectionalstudy
AT balkanilkerinanc evaluationofolfactoryfunctionwithobjectivetestsincovid19positivepatientsacrosssectionalstudy
AT yenerhmurat evaluationofolfactoryfunctionwithobjectivetestsincovid19positivepatientsacrosssectionalstudy
AT ozdoganhahmet evaluationofolfactoryfunctionwithobjectivetestsincovid19positivepatientsacrosssectionalstudy